Abstract: The present invention provides a method for reducing, or preventing, bone marrow hypoplasia in a patient at risk of, or having, same. To this end, when a glutathione intracellular stimulator is administered to such a patient, the risk of bone marrow hypoplasia is reduced or prevented. In an embodiment, the composition for stimulating the intracellular glutathione levels comprises L-2-oxothiazolidine-4-carboxylate.
Type:
Grant
Filed:
May 28, 1993
Date of Patent:
July 4, 1995
Assignee:
Free Radical Sciences, Inc.
Inventors:
Dennis I. Goldberg, Gary Pace, Randy D. White, Daniel M. Wilson